P

Assignee

DYAX CORP

US120 patents

Top patents by PatentIndex Score

US7064107B2Jun 20, 2006

Prevention and reduction of blood loss

DYAX CORP86 citations99
US6423498B1Jul 23, 2002

Variegated Kunitz domain peptide library and uses thereof

DYAX CORP143 citations99
US6333402B1Dec 25, 2001

Kallikrein-binding “Kunitz domain” proteins and analogues thereof

DYAX CORP115 citations99
US6057287AMay 2, 2000

Kallikrein-binding "Kunitz domain" proteins and analogues thereof

DYAX CORP125 citations99
US6010880AJan 4, 2000

Inhibitors of human plasmin derived from the kunitz domains

DYAX CORP102 citations99
US5994125ANov 30, 1999

Kallikrein-inhibiting "Kunitz Domain" proteins and analogues thereof

DYAX CORP112 citations99
US5795865AAug 18, 1998

Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof

DYAX CORP145 citations99
US8044175B2Oct 25, 2011

Peptides that specifically bind HGF receptor (CMET) and uses thereof

DYAX CORP44 citations98
US7811991B2Oct 12, 2010

Prevention and reduction of blood loss

DYAX CORP48 citations98
US7276480B1Oct 2, 2007

Prevention and reduction of blood loss

DYAX CORP76 citations98
US7235530B2Jun 26, 2007

Kallikrein inhibitors and anti-thrombolytic agents and uses thereof

DYAX CORP103 citations98
US7208293B2Apr 24, 2007

Directed evolution of novel binding proteins

DYAX CORP94 citations98
US7118879B2Oct 10, 2006

Method of recovering a nucleic acid encoding a proteinaceous binding domain which binds a target material

DYAX CORP80 citations98
US6979538B2Dec 27, 2005

Directed evolution of novel binding proteins

DYAX CORP80 citations98
US5663143ASep 2, 1997

Engineered human-derived kunitz domains that inhibit human neutrophil elastase

DYAX CORP272 citations98
US7244592B2Jul 17, 2007

Ligand screening and discovery

DYAX CORP64 citations97
US6103499AAug 15, 2000

Inhibitors of human plasmin derived from the Kunitz domains

DYAX CORP79 citations97
US6071723AJun 6, 2000

Inhibitors of human plasmin derived from the Kunitz domains

DYAX CORP78 citations97
US5837500ANov 17, 1998

Directed evolution of novel binding proteins

DYAX CORP595 citations97
US7919462B2Apr 5, 2011

Inhibitors of human plasmin derived from the Kunitz domains

DYAX CORP29 citations96
US7851442B2Dec 14, 2010

Prevention and reduction of blood loss

DYAX CORP46 citations96
US7628983B2Dec 8, 2009

Kallikrein-binding “Kunitz domain” proteins and analogues thereof

DYAX CORP48 citations96
US7261876B2Aug 28, 2007

Multivalent constructs for therapeutic and diagnostic applications

DYAX CORP33 citations96
US6989369B2Jan 24, 2006

Kunitz domain peptides

DYAX CORP53 citations96
US6953674B2Oct 11, 2005

Inhibitors of human plasmin derived from the kunitz domains

DYAX CORP31 citations96
US9034601B2May 19, 2015

Multi-chain eukaryotic display vectors and uses thereof

DYAX CORP26 citations95
US7211240B2May 1, 2007

Multivalent constructs for therapeutic and diagnostic applications

DYAX CORP52 citations95
US7153829B2Dec 26, 2006

Kallikrein-inhibitor therapies

DYAX CORP62 citations95
US6294087B1Sep 25, 2001

Chromatography column

DYAX CORP48 citations95
US6221252B1Apr 24, 2001

Module and method for introducing a sample into a chromatography column

DYAX CORP39 citations95
US6139733AOct 31, 2000

Module and method for introducing a sample into a chromatography column

DYAX CORP67 citations95
US5601708AFeb 11, 1997

Apparatus for pressurizing a removable chromatography cartridge

DYAX CORP92 citations95
US10370453B2Aug 6, 2019

Plasma kallikrein binding proteins

DYAX CORP25 citations94
US9266964B2Feb 23, 2016

Method of treating hereditary angioedema using plasma kallikrein binding antibodies

DYAX CORP24 citations94
US7704949B2Apr 27, 2010

Kallikrein-inhibitor therapies

DYAX CORP33 citations94
US7329737B2Feb 12, 2008

Antibodies that bind hK-1

DYAX CORP54 citations94
US7166576B2Jan 23, 2007

Methods for preserving organs and tissues

DYAX CORP72 citations94
US6171486B1Jan 9, 2001

Liquid chromatography column

DYAX CORP102 citations94
US10428158B2Oct 1, 2019

Compositions and methods for treatment of diabetic macular edema

DYAX CORP14 citations93
US6984373B2Jan 10, 2006

Fibrin binding moieties useful as imaging agents

DYAX CORP57 citations93
US6451260B1Sep 17, 2002

Method for producing microporous elements, the microporous elements thus produced and uses thereof

DYAX CORP153 citations93
US10336832B2Jul 2, 2019

Methods of inhibiting plasma kallikrein in edema patient

DYAX CORP13 citations92
US9556428B2Jan 31, 2017

Multi-chain eukaryotic display vectors and uses thereof

DYAX CORP8 citations92
US9260520B2Feb 16, 2016

Antibodies to FeRn and uses thereof

DYAX CORP18 citations92
US8034775B2Oct 11, 2011

Kallikrein-inhibitor therapies

DYAX CORP25 citations92
US7893007B2Feb 22, 2011

Directed evolution of novel binding proteins

DYAX CORP22 citations92
US7718617B2May 18, 2010

Methods for preserving organs and tissues

DYAX CORP43 citations92
US7485297B2Feb 3, 2009

Method of inhibition of vascular development using an antibody

DYAX CORP35 citations92
US7413537B2Aug 19, 2008

Directed evolution of disulfide-bonded micro-proteins

DYAX CORP40 citations92
US7078383B2Jul 18, 2006

ITI-D1 Kunitz domain mutants as HNE inhibitors

DYAX CORP28 citations92

Showing the top 50 of 120 patents by PatentIndex Score.